Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
1 "Dong Il Sun"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Article
Adjuvant Postoperative Radiotherapy with or without Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: The Importance of Patient Selection for the Postoperative Chemoradiotherapy
Jong Hoon Lee, Jin Ho Song, Sang Nam Lee, Jin Hyoung Kang, Min Sik Kim, Dong Il Sun, Yeon-Sil Kim
Cancer Res Treat. 2013;45(1):31-39.   Published online March 31, 2013
DOI: https://doi.org/10.4143/crt.2013.45.1.31
AbstractAbstract PDFPubReaderePub
PURPOSE
We wanted to evaluate the role of postoperative chemoradiotherapy (CRT) for patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
MATERIALS AND METHODS
From March 1993 to July 2008, 101 patients with advanced SCCHN and who had undergone macroscopically complete resection were enrolled. Survival and the cumulative incidence of local or regional relapse, metastasis, and acute toxicity were analyzed.
RESULTS
There was a marginally significant difference of disease-free survival at five years in favor of the CRT arm (51.3% vs. 41.8%, respectively; p=0.10). However, there was no significant difference in overall survival between the two treatment arms (p=0.20). The rate of locoregional failure only for the radiotherapy arm was significantly higher than that for the CRT arm (23.2% vs. 4.4%, respectively; p=0.01). The incidence of grade 3 or 4 hematologic toxicity was significantly higher in the CRT arm than that in the radiotherapy arm (37.7% vs. 1.7%, respectively; p=0.01). In CRT arm, early mortality group within 1 year had low performance status and old age over sixty compared with those of the others.
CONCLUSION
After curative-intent surgery, adjuvant CRT is more effective in locoregional tumor control than radiotherapy alone for patients with advanced SCCHN. However, compared with radiotherapy alone, this combined modality treatment had no survival benefit, and was significantly associated with increased toxicity. Thus, patients with low performance status and old age must be cautious in selection of toxic trimodality treatment.

Citations

Citations to this article as recorded by  
  • Modern management of distant metastases from head and neck squamous cell carcinoma
    Patrick Bradley, Claudia Montenegro, Cesare Piazza
    Current Opinion in Otolaryngology & Head & Neck Surgery.2025; 33(2): 115.     CrossRef
  • Therapeutic Drug Monitoring of 5-Fluorouracil in Head and Neck Cancer Patients: An Interventional Pilot Study
    P. Sharmila Nirojini, N.K. Bhuvaneshwari, N. Dharsshini, S. Dhivya Bharathi, K. Velavan
    Indian Journal of Medical and Paediatric Oncology.2024; 45(02): 134.     CrossRef
  • Factors Associated with Patient Survival in Clear Cell Adenocarcinoma of the Cervix: A Single-Center Experience in China
    Ting Wang, Zhiying Lu, Xiaodan Zhang, Keqin Hua
    International Journal of General Medicine.2022; Volume 15: 4625.     CrossRef
  • Adding Concomitant Chemotherapy to Postoperative Radiotherapy in Oral Cavity Carcinoma with Minor Risk Factors: Systematic Review of the Literature and Meta-Analysis
    Alessia Di Rito, Francesco Fiorica, Roberta Carbonara, Francesca Di Pressa, Federica Bertolini, Francesco Mannavola, Frank Lohr, Angela Sardaro, Elisa D’Angelo
    Cancers.2022; 14(15): 3704.     CrossRef
  • Metastatic disease in head & neck oncology
    Paolo Pisani, Mario Airoldi, Anastasia Allais, Paolo Aluffi Valletti, Mariapina Battista, Marco Benazzo, Roberto Briatore, Salvatore Cacciola, Salvatore Cocuzza, Andrea Colombo, Bice Conti, Alberto Costanzo, Laura della Vecchia, Nerina Denaro, Cesare Fant
    Acta Otorhinolaryngologica Italica.2020; 40(SUPPL. 1): S1.     CrossRef
  • The Efficacy of Low Postoperative Radiation Dose in Patients with Advanced Hypopharyngeal Cancer without High-Risk Factors


    Hengmin Tao, Zhong Shen, Zhichao Liu, Yumei Wei
    Cancer Management and Research.2020; Volume 12: 7553.     CrossRef
  • Contemporary treatment patterns and outcomes of salivary gland carcinoma: a National Cancer Database review
    Jay K. Ferrell, Jess C. Mace, Daniel Clayburgh
    European Archives of Oto-Rhino-Laryngology.2019; 276(4): 1135.     CrossRef
  • Detection of high PD-L1 expression in oral cancers by a novel monoclonal antibody L1Mab-4
    Shinji Yamada, Shunsuke Itai, Mika K. Kaneko, Yukinari Kato
    Biochemistry and Biophysics Reports.2018; 13: 123.     CrossRef
  • Postoperative radiotherapy dose requirement in standard combined-modality practice for head and neck squamous cell carcinoma: Analysis of salient surgical and radiotherapy parameters in 2 cohorts
    Bidhu K. Mohanti, Alok Thakar, Jaspreet Kaur, Sudhir Bahadur, Monica Malik, Ajeet K. Gandhi, Suman Bhasker, Atul Sharma
    Head & Neck.2017; 39(9): 1788.     CrossRef
  • Silencing of FANCD2 enhances the radiosensitivity of metastatic cervical lymph node-derived head and neck squamous cell carcinoma HSC-4 cells
    Hua-Jun Feng, Yi-Lin Bao, Zhuo-Ping Liang, Fei-Peng Zhao, Sheng-En Xu, Wei Xu, Chong Zhao, Gang Qin
    International Journal of Oncology.2017; 50(4): 1241.     CrossRef
  • Do circulating long non-coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) predict the treatment response in patients with head and neck cancer treated with chemoradiotherapy?
    Merdan Fayda, Mustafa Isin, Makbule Tambas, Murat Guveli, Rasim Meral, Musa Altun, Dilek Sahin, Gozde Ozkan, Yasemin Sanli, Husniye Isin, Emre Ozgur, Ugur Gezer
    Tumor Biology.2016; 37(3): 3969.     CrossRef
  • Diagnostic and therapeutic features associated with modification of quality-of-life's outcomes between one and six months after major surgery for head and neck cancer
    Margherita Gobbo, Federica Bullo, Giuseppe Perinetti, Annalisa Gatto, Giulia Ottaviani, Matteo Biasotto, Giancarlo Tirelli
    Brazilian Journal of Otorhinolaryngology.2016; 82(5): 548.     CrossRef
  • Recurrence patterns after postoperative radiotherapy for squamous cell carcinoma of the pharynx and larynx
    Yusuke Iizuka, Michio Yoshimura, Haruo Inokuchi, Yukinori Matsuo, Akira Nakamura, Takashi Mizowaki, Shigeru Hirano, Morimasa Kitamura, Ichiro Tateya, Masahiro Hiraoka
    Acta Oto-Laryngologica.2015; 135(1): 96.     CrossRef
  • Chemotherapy of Head and Neck Cancer
    Chang Ki Yeo
    Korean Journal of Otorhinolaryngology-Head and Neck Surgery.2014; 57(5): 291.     CrossRef
  • Photochemotherapeutic effects of UV-C on acridine orange in human breast cancer cells: potential application in anticancer therapy
    Arunkumar Pitchaimani, Arun Renganathan, Selvamurugan Cinthaikinian, Kumpati Premkumar
    RSC Advances.2014; 4(42): 22123.     CrossRef
  • Analysis of the Prognostic Factors for Distant Metastasis after Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Head and Neck Cancer
    Dong Hyun Kim, Won Taek Kim, Joo Hye Lee, Yong Kan Ki, Ji Ho Nam, Byung Joo Lee, Jin Choon Lee, Young Jin Choi, Young Mi Seol, Dong Won Kim
    Cancer Research and Treatment.1970; 47(1): 46.     CrossRef
  • 25,022 View
  • 84 Download
  • 16 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP